Blog Documentation Prescription Filling 
FDA Law Blog: Biosimilars
DECEMBER 4, 2023
Within one month of each comprehensive review, the pharmacy must prepare a written report identifying prescriptions filled that were not issued for a legitimate medical purpose or filled outside the usual course of the professional practice of pharmacy, and prescriptions in violation of the permanent injunction terms.
Proxsys Rx
DECEMBER 8, 2022
Before a TPA can provide your health system with support, your data team must automate a data feed from your EHR to your TPA — one which documents 340B-eligible patient encounters. 340B program support fee structures In general, you should avoid TPAs that charge fees for every pharmacy prescription fill they assess.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Ramblings of a pharmacist
FEBRUARY 16, 2022
I have read Adam Fein’s Drug Channels blog for about a decade now. source material in his blog, a person can become quite well-informed about the pharmacy industry. I’ll also note that I’m not certain that the “Pharmacy” revenue is ONLY prescription fills. prescription transaction. (If
Putting Patients First Blog
SEPTEMBER 3, 2024
We recommend that CMS offer more specific sub-questions, similar to other questions in the document, aimed at prioritizing the identification of health disparities that may affect access to and outcomes from the selected drug. Prior authorization and association with delayed or discontinued prescription fills. and Keating, N.
Putting Patients First Blog
JULY 2, 2024
The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Prior authorization and association with delayed or discontinued prescription fills. and Keating, N. Journal of Clinical Oncology, 42(8). link] xii Chino, F.,
Expert insights. Personalized for you.
139 
Let's personalize your content